Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states.
about
Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activationHerbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.Tritium-labelled alkaloids: Synthesis and applications.Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.Revealing binding interaction between seven drugs and immobilized β2-adrenoceptor by high-performance affinity chromatography using frontal analysis.
P2860
Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Interaction of ibogaine with h ...... fferent conformational states.
@ast
Interaction of ibogaine with h ...... fferent conformational states.
@en
Interaction of ibogaine with h ...... fferent conformational states.
@nl
type
label
Interaction of ibogaine with h ...... fferent conformational states.
@ast
Interaction of ibogaine with h ...... fferent conformational states.
@en
Interaction of ibogaine with h ...... fferent conformational states.
@nl
prefLabel
Interaction of ibogaine with h ...... fferent conformational states.
@ast
Interaction of ibogaine with h ...... fferent conformational states.
@en
Interaction of ibogaine with h ...... fferent conformational states.
@nl
P2093
P2860
P1476
Interaction of ibogaine with h ...... ifferent conformational states
@en
P2093
Avraham Rosenberg
Dominik Feuerbach
Hugo R Arias
Irving W Wainer
Ruin Moaddel
Xiao Juan Yuan
P2860
P304
P356
10.1016/J.BIOCEL.2010.05.011
P577
2010-09-01T00:00:00Z